Key Financial Data Of Reporting Company

Carna Biosciences, Inc. - Filing #7595165

Concept 2022-01-01 to
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-06-30
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-06-30
2021-01-01 to
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
839,543,000 JPY
2,017,529,000 JPY
430,010,000 JPY
Ordinary profit (loss)
-306,431,000 JPY
-522,992,000 JPY
-774,731,000 JPY
Net assets
4,425,947,000 JPY
4,315,572,000 JPY
3,096,723,000 JPY
Total assets
5,218,214,000 JPY
5,432,560,000 JPY
3,662,494,000 JPY
Basic earnings (loss) per share
-26.53
-25.25
-42.10
-62.56
-39.46
Diluted earnings per share
Equity-to-asset ratio
0.847 xbrli:pure
0.793 xbrli:pure
0.845 xbrli:pure
Net cash provided by (used in) operating activities
585,341,000 JPY
-1,536,612,000 JPY
-963,337,000 JPY
Net cash provided by (used in) investing activities
-57,309,000 JPY
-41,677,000 JPY
-34,339,000 JPY
Net cash provided by (used in) financing activities
166,348,000 JPY
1,064,987,000 JPY
-102,287,000 JPY
Cash and cash equivalents
4,684,699,000 JPY
3,817,834,000 JPY
3,213,070,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.